Navigation Links
Long-Term Results of VisionCare's Implantable Telescope for End-Stage Macular Degeneration Published in the American Journal of Ophthalmology
Date:11/5/2008

- Report shows three-line average visual acuity improvement maintained at

two years -

SARATOGA, Calif., Nov. 5 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for individuals with age-related macular degeneration (AMD), today announced that the American Journal of Ophthalmology (AJO), a premier peer-reviewed medical journal, has published two-year results from the Phase II/III IMT002 trial showing substantial visual acuity improvement in End-Stage AMD patients. The study device, a first-of-kind implantable telescope, has received CE Mark approval in Europe and is currently investigational and under regulatory review by the U.S. Food and Drug Administration.

The publication details the two-year safety profile of the device and found rates of cornea endothelial cell loss, while higher than conventional small-incision anterior segment eye surgery, were consistent with anterior segment procedures employing more similar incision sizes required for telescope implantation.

"The published data show improved visual acuity in end-stage AMD patients that was maintained over two years -- a three-line improvement that we have previously shown makes a real impact on our patients' independence and quality of life," said Henry L. Hudson, M.D., lead author for the IMT002 study and retina specialist at Retina Centers, P.C. in Tucson, AZ. "These findings are important because vision loss from end-stage AMD profoundly affects both the daily activities and social well-being of many older Americans."

"The data presented in AJO confirm the effectiveness of the AMD telescope prosthesis and the long-term safety profile of the device," stated R. Doyle Stulting, M.D., Ph.D., professor of ophthalmology at Emory University in Atlanta and study coauthor. "Key indicators of corneal health and diagnostic verification of device placement substantiate earlier findings that ri
'/>"/>

SOURCE VisionCare Ophthalmic Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. AlBaraka Islamic Bank Builds on a Long-Term Partnership With Misys Selecting Misys Equation and Trade Innovation for its Pakistan Operations
2. GSU study first to confirm long-term benefits of morphine treatment in infants
3. State and National Leaders Call for Long-term Care Financing Reform
4. No Difference in Rate of Survival for Children of Different Races Undergoing Liver Transplantation, but Long-Term Results Not as Good for African-American Adults
5. Early Liver Transplantation Regardless of Donor Type Increases Long-term Survival
6. deCODE Conducting Strategic Review to Sharpen the Focus of its Long-term Business
7. Tennessee Introduces Long-Term Care Partnership Insurance Policies and Producer Training Requirement
8. Getting help for depression and anxiety has significant long-term benefits
9. State Medicaid Programs to Spend $1.6 Trillion on Long-Term Care over the Next Twenty Years
10. Top Insurance Expert Calls on 144,000 Holders of Long-Term Care Polices to Protest an Eleventh Hour Conseco Trust
11. Five Steps for Staying in Financial Control with Long-Term Disability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Liberty University has received accreditation ... program from the Council for Accreditation of Counseling & ... Liberty’s Center for Counseling & Family Studies , is ... the university’s new School of Behavioral Sciences. Prior to the ...
(Date:1/22/2015)... 22, 2015 Gabe’s Chemo Duck Program is pleased ... first app ever created for kids with cancer. The Chemo Duck ... devices, is filled with enjoyable games to help children of all ... free app helps to keep kids entertained, educated and at ease ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 Angelweddingdress is a ... business invites its customers to follow it on Facebook, Twitter, ... a Valentine’s Day gift. Angelweddingdress draws a lottery every week. ... Sale to Feb. 28, 2015. Click Angelweddingdress homepage ...
(Date:1/22/2015)... 22, 2015 Juvent Sports ( http://www.juventsports.com ... 2015 PGA Merchandise Show to bestow a Juvent Sports ... amateur golfer, Arlene McKitrick. The award commemorated and congratulated ... tournament win. She won her first amateur tournament in ...
(Date:1/22/2015)... 22, 2015 For over 20 years, Dr. David ... and Vista area has treated just about every type of ... circumstances. And for those same twenty-plus years, the team at ... those injuries with the best possible doctor. With the ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2
... hernia surgeries in 13 hours, 41 minutes and 19 seconds ... // ,The surgeon Dr J S Rajkumar, chairman, Lifeline ... surgeries in 24 hours. ,The patients on whom ... exercise was backed by a team of dedicated professionals and ...
... Recent studies conducted on bird flu vaccine has now established that ... bird flu crisis may not be as effective as it is ... the companies developing such a vaccine named as generic H5N1 and ... be in production by the end of the year, and is ...
... Heart and Stroke Foundation of Canada has issued a wake up ... in the advancement of heart health. // ,Dr. Beth ... that the rates of obesity in baby boomers have soared by ... inactive." ,Abramson feels that baby boomers, the group between ...
... of great joy and expectation as both the expectant mother ... women however are not able to experience the bliss due ... more than psychological distress. A few of the factors that ... special report. , Abuse during pregnancy: Abuse ...
... coffee, it as been found in a study that drinking coffee ... that consumption should be moderate. Its moderate consumption every day may ... ,Previous studies in US had linked drinking more than two cups ... of chronic liver disease. ,This new study by Harvard ...
... spurred by the inability or failure to ‘Gasp’. But now, ... probable cause of SIDS. // ,University of Bristol ... that are capable of producing nervous impulses on their ... ‘pacemakers.' ,The research team, led by Professor Julian Paton ...
Cached Medicine News:Health News:Do Women Die In Childbirth Because It Is More Preferable? 2Health News:Do Women Die In Childbirth Because It Is More Preferable? 3
(Date:1/23/2015)... Gem Pharmaceuticals announced today that the initial soft ... Company,s Phase 2 clinical trial.  This open-label study will ... GPX-150 (an investigational medication), in approximately 30 adults as ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO GPX-150 ...
(Date:1/22/2015)... MINNEAPOLIS, Jan. 22, 2015  Uroplasty, Inc. (NASDAQ: UPI ... markets innovative proprietary products to treat voiding dysfunctions, today ... ended December 31, 2014.  Global revenue for the ... $4.4 million, a new quarterly revenue record, as compared ...
(Date:1/22/2015)... 22, 2015  Profil Institute for Clinical Research, Inc., a ... announced today a new textbook,  Translational Research Methods for ... a leading global scientific publisher. The textbook ... for use in early phase clinical studies of new ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3
... April 16, 2012 genae, a leading Contract ... industries, today announced that Catalina Trana, MD, has been appointed ... responsible for all clinical, safety and risk management related to ... Catalina, whose extensive clinical and research expertise will be of ...
... subsidiary of Eisai Inc., announced today that it has ... and efficacy of MORAb-004 in the treatment of metastatic ... MORAb-004 is a monoclonal antibody that specifically binds to ... is a randomized, double-blind, placebo-controlled study to assess the ...
Cached Medicine Technology:genae Appoints Chief Medical Officer 2Morphotek®, Inc. Announces Initiation of MORAb-004 Phase 2 Study in Metastatic Colorectal Cancer 2Morphotek®, Inc. Announces Initiation of MORAb-004 Phase 2 Study in Metastatic Colorectal Cancer 3
Used to provide drainage of urine from the bladder. All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open packages. Inte...
... Used for temporary ... ureteropelvic junction to the ... Supplied sterile in peel-open ... use. CAUTION: Periodic evaluation ...
Used for stenting the urethra during hypospadias or epispadias repair and to allow post-operative drainage of the bladder. Supplied sterile in peel-open packages. Intended for one-time use....
Used for stenting the urethra after hypospadias or epispadias repair and to provide post-operative drainage of the bladder. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: